Top Markets
Coin of the day
Gongwin Biopharm Holdings Co., Ltd. Gongwin Biopharm Holdings Co., Ltd.

Gongwin Biopharm Holdings Co., Ltd.

6617
Classement en actions #13752
Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical... Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the development of oncology therapeutics. The company's robust pipeline features several drug candidates, including PTS302, which has successfully concluded Phase III clinical trials for lung cancer. Additionally, PTS100 is currently progressing through Phase II clinical trials for liver cancer, while PTS-02 is being developed to address adenoid cystic carcinoma, and PTS500 targets malignant pleural effusion. Established in 2014, Gongwin Biopharm is headquartered in Taipei, Taiwan.
Prix de l'action
$3.83
Capitalisation boursière
$464.45M
Changement (1 jour)
-1.63%
Changement (1 an)
17.17%
Pays
TW
Échange Gongwin Biopharm Holdings Co., Ltd. (6617)

Catégorie

Historique du prix de l'action pour Gongwin Biopharm Holdings Co., Ltd. (6617)
Prix de clôture le plus élevé : $3.43 le 2026-08-01

Prix de clôture le plus bas : $2.71 le 2017-02-01
Historique du prix de l'action de Gongwin Biopharm Holdings Co., Ltd. de 2017 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -1.11%
2025 -19.11%
2024 -45.63%
2023 -41.34%
2022 10.61%
2021 7.85%
2020 318.74%
2019 -1.25%
2018 12.21%
2017 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$885.01 28.89%
US
$323.36 10.89%
US
$234.55 57.65%
US
$187.22 0.00%
US
$1.90 -7.01%
AU